Sort
40,608 grants matching “prostate cancer”
Role of STEAP2 protein in hepatocarcinogenesis
$429,775Luzhe Sun · University Of Texas Hlth Science Center · R01 · FY2023 · CA
Prostate-Specific Antigen Practices and Outcomes in the Elderly
$429,697Louise C. Walter · Northern California Institute/Res/Edu · R01 · FY2011 · CA
Project 2: Combined CAR-T cell therapy
$429,640Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA
HIGH-PRECISION IMAGE-GUIDED RADIOTHERAPY OF THE PROSTATE
$429,596University Health Network · R21 · FY2002 · AG
PROSTATE CANCER STEM CELLS INTERACT WITH IMMUNE AND INFLAMMATORY CELLS DURING HORMONE-REFRACTORY PROSTATE CANCER EVOLUTION
$429,525Scripps Research Institute · · FY2009 · Department of the Army
Personal Patient Profile-Prostate (P4) Randomized, Multi-site Trial
$429,523Seth Wolpin · University Of Washington · R01 · FY2008 · NR
NIMHD Adjunct Investigator Program
$429,520Kelvin Choi · National Institute On Minority Health And Health Disparities · ZIJ · FY2024 · MD
Cancer-prone cell states of the fallopian tubal epithelium
$429,513Alexander Y Nikitin · Cornell University · R01 · FY2021 · CA
Cancer-prone cell states of the fallopian tubal epithelium
$429,513Alexander Y Nikitin · Cornell University · R01 · FY2025 · CA
Project 2: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment during tumor growth and progression in ATL
$429,511Deborah V Novack · Ohio State University · P01 · FY2023 · CA
p53 Variants in Cancer Risk and Therapy
$429,501Maureen E Murphy · Wistar Institute · R01 · FY2020 · CA
ARCHER - An Extremely Fast Medical Radiation Dose Computing Software
$429,479Xie George Xu · Virtual Phantoms, Inc. · R42 · FY2016 · EB
Drug Mechanism of Action-based targeting of tumor subpopulations
$429,473Andrea Califano · Columbia University Health Sciences · U54 · FY2024 · CA
Extracellular vesicle enclosed circular RNA and interferon responses in tumor host interactions.
$429,399Dolores Di Vizio · Cedars-Sinai Medical Center · R21 · FY2025 · CA
A SHARED TISSUE RESOURCE FOR THE MOLECULAR CLASSIFACTION
$429,327University Of Pittsburgh At Pittsburgh · U01 · FY2005 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$429,318James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
METABOLIC IMAGING OF THE PROSTATE USING 3-D MRSI
$429,307Daniel B Vigneron · University Of California, San Francisco · R01 · FY2009 · CA
Evaluation of Immune-based Combinations in Metastatic Prostate Cancer
$429,279Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Targeting KDM4B, a novel alternative splicing regulator, in castration-resistant prostate cancer (CRPC)
$429,276Zhi-Ping Liu · Ut Southwestern Medical Center · R01 · FY2018 · CA
The Role of YY1 in Castration-Resistant Prostate Cancer
$429,272Ling Cai · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Molecular and Cell Biology
$429,209Joseph R Landolph · University Of Southern California · P30 · FY2007 · CA
Structure and dynamics of clinically-relevant cytochrome P450 enzymes
$429,111Emily E Scott · University Of Michigan At Ann Arbor · R01 · FY2021 · GM
Structure and dynamics of clinically-relevant cytochrome P450 enzymes
$429,111Emily E Scott · University Of Michigan At Ann Arbor · R01 · FY2022 · GM
Structure and dynamics of clinically-relevant cytochrome P450 enzymes
$429,111Emily E Scott · University Of Michigan At Ann Arbor · R01 · FY2020 · GM
Core C: Community Outreach and Engagement
$429,075Samuel Lefridge Washington III · University Of California, San Francisco · U54 · FY2025 · CA